This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Zosano Pharma 대차 대조표 상태
재무 상태 기준 확인 4/6
주요 정보
0%
부채 비율
US$0
부채
이자 보상 비율 | n/a |
현금 | US$13.53m |
주식 | US$14.05m |
총 부채 | US$12.39m |
총 자산 | US$26.45m |
최근 재무 상태 업데이트
Can Zosano Pharma (NASDAQ:ZSAN) Afford To Invest In Growth?
Nov 02Is Zosano Pharma (NASDAQ:ZSAN) Weighed On By Its Debt Load?
Jun 29Recent updates
Can Zosano Pharma (NASDAQ:ZSAN) Afford To Invest In Growth?
Nov 02Is Zosano Pharma (NASDAQ:ZSAN) Weighed On By Its Debt Load?
Jun 29Data supports long-term benefit of Zosano's migraine candidate; shares surge 23%
May 26Zosano Pharma: Early PK+Safety Study In Q3 2021 May Breathe New Life Into This Biotech
Apr 30Zosano shares rise on migraine treatment NDA resubmission update
Apr 26Auditors Have Doubts About Zosano Pharma (NASDAQ:ZSAN)
Mar 15Zosano Pharma up 21% following FDA feedback on Qtrypta application; presents Qtrypta data in migraine
Feb 01Zosano Pharma requests FDA meeting for its Qtrypta application
Jan 04Zosano Pharma EPS misses by $0.01
Nov 13재무 상태 분석
단기부채: ZSAN.Q's short term assets ($15.6M) exceed its short term liabilities ($9.7M).
장기 부채: ZSAN.Q's short term assets ($15.6M) exceed its long term liabilities ($2.7M).
부채 대 자본 내역 및 분석
부채 수준: ZSAN.Q is debt free.
부채 감소: ZSAN.Q has no debt compared to 5 years ago when its debt to equity ratio was 39.1%.
대차 대조표
현금 런웨이 분석
과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.
안정적인 현금 활주로: ZSAN.Q has less than a year of cash runway based on its current free cash flow.
예측 현금 활주로: ZSAN.Q has less than a year of cash runway if free cash flow continues to reduce at historical rates of 7.4% each year